insights_auto
Why is ORX up 2.35%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
SEKÂ 0.87
arrow_upward
+2.35%(+0.020) 1D
Nov 17, 4:26:26 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
SEKÂ 0.83
High
SEKÂ 0.98
Low
SEKÂ 0.83
Mkt. cap
305.61M
Avg. vol.
790.03K
Volume
655.06K
P/E ratio
0.06
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
Open
SEKÂ 0.83
High
SEKÂ 0.98
Low
SEKÂ 0.83
Mkt. cap
305.61M
Avg. vol.
790.03K
Volume
655.06K
P/E ratio
0.06
52-wk high
SEKÂ 22.55
52-wk low
SEKÂ 0.80
EPS
SEKÂ 13.61
Shares outstanding
35.13M
No. of employees
55
News stories
From web sources and news partners
TradingView
·
2 hours ago
Stock Market Today: Dow Jones, S&P 500, Nasdaq 100 Futures Trade Mixed Ahead of Nvidia’s Q3 Earnings— CBRS, AMZN, RCAT in Focus (UPDATED)
The Motley Fool
·
1 hour ago
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
Coinpaper
·
46 minutes ago
Stock Market Today: S&P 500 Struggles Ahead of Nvidia Earnings After $2 Trillion Stock Rout
Traders Union
·
1 hour ago
S&P 500 could deliver 18% total return by 2027, Goldman Sachs projects
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEONikolaj Sørensen
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com